John Smither Rejoins Arcutis as Interim CFO
Arcutis Biotherapeutics, a biopharmaceutical company focused on pioneering advancements in immuno-dermatology at an early commercial stage, has announced the appointment of John W. Smither as interim Chief Financial Officer (CFO), effective August 31. John previously held the role of Arcutis' inaugural CFO from 2019 to 2021. He will be taking...